Intelligent Bio Solutions (NASDAQ:INBS – Get Free Report) and Alignment Healthcare (NASDAQ:ALHC – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk.
Valuation and Earnings
This table compares Intelligent Bio Solutions and Alignment Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Intelligent Bio Solutions | $3.05 million | 1.86 | -$10.57 million | ($12.22) | -0.19 |
| Alignment Healthcare | $3.95 billion | 1.11 | -$720,000.00 | $0.09 | 236.56 |
Risk & Volatility
Intelligent Bio Solutions has a beta of 4.21, indicating that its stock price is 321% more volatile than the S&P 500. Comparatively, Alignment Healthcare has a beta of 1.14, indicating that its stock price is 14% more volatile than the S&P 500.
Insider & Institutional Ownership
33.0% of Intelligent Bio Solutions shares are owned by institutional investors. Comparatively, 86.2% of Alignment Healthcare shares are owned by institutional investors. 1.3% of Intelligent Bio Solutions shares are owned by company insiders. Comparatively, 5.2% of Alignment Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Profitability
This table compares Intelligent Bio Solutions and Alignment Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Intelligent Bio Solutions | -296.73% | -176.09% | -89.71% |
| Alignment Healthcare | 0.47% | 11.50% | 1.79% |
Analyst Recommendations
This is a summary of recent ratings and price targets for Intelligent Bio Solutions and Alignment Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Intelligent Bio Solutions | 1 | 0 | 0 | 0 | 1.00 |
| Alignment Healthcare | 0 | 3 | 6 | 1 | 2.80 |
Alignment Healthcare has a consensus price target of $24.30, indicating a potential upside of 14.14%. Given Alignment Healthcare’s stronger consensus rating and higher possible upside, analysts clearly believe Alignment Healthcare is more favorable than Intelligent Bio Solutions.
Summary
Alignment Healthcare beats Intelligent Bio Solutions on 13 of the 15 factors compared between the two stocks.
About Intelligent Bio Solutions
Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.
About Alignment Healthcare
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.
Receive News & Ratings for Intelligent Bio Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Bio Solutions and related companies with MarketBeat.com's FREE daily email newsletter.
